Keyphrases
Androgen Receptor
100%
Hypoxia
100%
Prostate Cancer Cells
100%
Androgen Signaling
100%
Androgens
36%
R1881
36%
Responsive Element
27%
Hypoxia Treatment
27%
Prostate-specific Antigen
18%
Receptor Function
18%
Stimulatory Effect
18%
Microenvironment
9%
Reporter Gene
9%
Confocal Microscopy
9%
Androgen Deprivation Therapy
9%
Prostate Cancer
9%
Tumor
9%
Chromatin Immunoprecipitation (ChIP)
9%
DU145
9%
Receptor Binding
9%
Prostate Radiotherapy
9%
Gene Activity
9%
Tissue Oxygenation
9%
Most Common Form
9%
Treatment Resistance
9%
Tumor Hypoxia
9%
Ligand-dependent
9%
LNCaP
9%
Hypoxia-reoxygenation
9%
Transient Hypoxia
9%
Receptor Transactivation
9%
Synthetic Androgen
9%
Recurrent Prostate Cancer
9%
Hypoxic Tumors
9%
Poor Clinical Outcomes
9%
Normoxic Conditions
9%
Tumor Environment
9%
Receptor Translocation
9%
Receptor Recruitment
9%
Medicine and Dentistry
Prostate Cancer
100%
Androgen Receptor
100%
Hypoxia
100%
Cancer Cell
100%
Androgen
42%
Metribolone
28%
Neoplasm
14%
Prostate Specific Antigen
14%
Sensitization
7%
Chromatin Immunoprecipitation
7%
Cancer Therapy
7%
Promoter Region
7%
Receptor Binding
7%
Reporter Gene
7%
Transactivation
7%
Gene Activity
7%
Confocal Microscopy
7%
Tumor Hypoxia
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen Receptor
100%
Hypoxia
100%
Androgen
42%
Metribolone
28%
Neoplasm
21%
Prostate Specific Antigen
14%
Chromatin Immunoprecipitation
7%
Confocal Microscopy
7%